4.7 Article

Higher Gestational Weight Gain Is Associated With Increasing Offspring Birth Weight Independent of Maternal Glycemic Control in Women With Type 1 Diabetes

期刊

DIABETES CARE
卷 37, 期 10, 页码 2677-2684

出版社

AMER DIABETES ASSOC
DOI: 10.2337/dc14-0896

关键词

-

资金

  1. European Foundation for the Study of Diabetes
  2. Rigshospitalet's Research Foundation
  3. Capital Region of Denmark
  4. Medical Faculty Foundation of Copenhagen University
  5. Aase and Ejnar Danielsen's Foundation
  6. Master Joiner Sophus Jacobsen and Astrid Jacobsen's Foundation
  7. Novo Nordisk Foundation
  8. Novo Nordisk Fonden [NNF14OC0009275] Funding Source: researchfish

向作者/读者索取更多资源

OBJECTIVE We evaluate the association between gestational weight gain and offspring birth weight in singleton term pregnancies of women with type 1 diabetes. RESEARCH DESIGN AND METHODS One hundred fifteen consecutive women referred at <14 weeks were retrospectively classified as underweight (prepregnancy BMI <18.5 kg/m(2); n = 1), normal weight (18.5-24.9; n = 65), overweight (25.0-29.9; n = 39), or obese (>= 30.0; n = 10). Gestational weight gain was categorized as excessive, appropriate, or insufficient according to the Institute of Medicine recommendations for each BMI class. Women with nephropathy, preeclampsia, and/or preterm delivery were excluded because of restrictive impact on fetal growth and limited time for total weight gain. RESULTS HbA(1c) was comparable at similar to 6.6% (49 mmol/mol) at 8 weeks and similar to 6.0% (42 mmol/mol) at 36 weeks between women with excessive (n = 62), appropriate (n = 37), and insufficient (n = 16) gestational weight gain. Diabetes duration was comparable, and median prepregnancy BMI was 25.3 (range 18-41) vs. 23.5 (18-31) vs. 22.7 (20-30) kg/m(2) (P = 0.05) in the three weight gain groups. Offspring birth weight and birth weight SD score decreased across the groups (3,681 [2,374-4,500] vs. 3,395 [2,910-4,322] vs. 3,295 [2,766-4,340] g [P = 0.02] and 1.08 [-1.90 to 3.25] vs. 0.45 [-0.83 to 3.18] vs. -0.02 [-1.51 to 2.96] [P = 0.009], respectively). In a multiple linear regression analysis, gestational weight gain (kg) was positively associated with offspring birth weight (g) (beta = 19; P = 0.02) and birth weight SD score (beta = 0.06; P = 0.008) when adjusted for prepregnancy BMI, HbA1c at 36 weeks, smoking, parity, and ethnicity. CONCLUSIONS Higher gestational weight gain in women with type 1 diabetes was associated with increasing offspring birth weight independent of glycemic control and prepregnancy BMI.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

Pregnancy outcomes in women with type 1 diabetes using insulin degludec

Lene Ringholm, Nicoline Callesen Do, Peter Damm, Elisabeth Reinhardt Mathiesen

Summary: This study evaluated pregnancy outcomes in pregnant women with type 1 diabetes using degludec, an ultra-long-acting insulin analog, compared to other long-acting insulin analogs. The results showed that degludec had similar pregnancy outcomes as other long-acting insulin analogs in a real-world setting, suggesting that degludec can be continued throughout pregnancy.

ACTA DIABETOLOGICA (2022)

Article Endocrinology & Metabolism

Apolipoprotein D and transthyretin are reduced in female adolescent offspring of women with type 1 diabetes: The EPICOM study

Martin Overgaard, Tina Ravnsborg, Zuzana Lohse, Birgitte Bytoft, Tine D. Clausen, Rikke B. Jensen, Peter Damm, Kurt Hojlund, Claus H. Gravholt, Sine Knorr, Dorte M. Jensen

Summary: Exposure to maternal type 1 diabetes during pregnancy has sex-specific effects on offspring, impacting serum levels of proteins involved in lipid, metabolic and transport processes. Low levels of Apolipoprotein D may serve as an early risk marker for metabolic syndrome. Further investigation is needed to explore the potential link between Apolipoprotein D and cardiovascular disease.

DIABETIC MEDICINE (2022)

Review Endocrinology & Metabolism

Secular trend for increasing birthweight in offspring of pregnant women with type 1 diabetes: is improved placentation the reason?

Gernot Desoye, Lene Ringholm, Peter Damm, Elisabeth R. Mathiesen, Mireille N. M. van Poppel

Summary: Despite progress in blood glucose control, pregnancy in women with type 1 diabetes still poses risks for the fetus. Good glycemic control reduces the risk of fetal overgrowth, but hyperglycemia can still lead to fetal overnutrition and adiposity. Preventing fetal adiposity requires revised goal setting and continuous glucose monitoring.

DIABETOLOGIA (2023)

Editorial Material Endocrinology & Metabolism

Is the Biphasic Effect of Diabetes and Obesity on Fetal Growth a Risk Factor for Childhood Obesity?

Mireille N. M. van Poppel, Peter Damm, Elisabeth R. R. Mathiesen, Lene Ringholm, Cuilin Zhang, Gernot Desoye

Summary: In pregnancies of women with obesity or diabetes, neonates are often overgrown. This article focuses on possible growth deviations earlier in pregnancy and their potential contribution to neonatal overgrowth, suggesting that early-pregnancy growth reduction followed by in utero catch-up growth may confer a higher risk of obesity in later life.

DIABETES CARE (2023)

Review Endocrinology & Metabolism

Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets

Katrien Benhalima, Kaat Beunen, Sarah E. Siegelaar, Rebecca Painter, Helen R. Murphy, Denice S. Feig, Lois E. Donovan, Sarit Polsky, Elizabeth Buschur, Carol J. Levy, Yogish C. Kudva, Tadej Battelino, Lene Ringholm, Elisabeth R. Mathiesen, Chantal Mathieu

Summary: Maintaining glucose concentrations within target, appropriate gestational weight gain, lifestyle management, and using antihypertensive treatment and low-dose aspirin if necessary can reduce the risk of complications in pregnancies complicated by type 1 diabetes. Hybrid closed-loop insulin delivery systems show promise as a treatment option during pregnancy.

LANCET DIABETES & ENDOCRINOLOGY (2023)

Article Endocrinology & Metabolism

A qualitative investigation into the perceptions and experiences of the stigma attached to gestational diabetes mellitus among women in Denmark

Emma Davidsen, Helle Terkildsen Maindal, Molly Byrne, Louise Kelstrup, Per Ovesen, Peter Damm, Karoline Kragelund Nielsen

Summary: The aim of this study was to examine the perceptions of women with gestational diabetes mellitus (GDM) in Denmark, focusing on GDM-specific stigma. Through semi-structured interviews and analysis, five themes were identified including victim-blaming narrative, identity threat, non-disclosure and anticipated stigma, stigma in a clinical setting, and stigma reduction in a clinical setting. The study also found intersectionality between GDM-specific stigma, notions of being a good mother, and stigma associated with type 2 diabetes mellitus and overweight. GDM-specific stigma had implications for GDM care and management, such as not attending GDM screening and not wanting to disclose the diagnosis.

DIABETES RESEARCH AND CLINICAL PRACTICE (2023)

Article Endocrinology & Metabolism

Body Mass Index Trajectories in Children Exposed to Gestational Diabetes in Utero: A Nationwide Register-based Study

Maja Thogersen, Karoline Kragelund Nielsen, Rasmus Wibaek, Peter Damm, Rikke Beck Jensen, Helene Nielsen, Helle Terkildsen Maindal, Gregers Stig Andersen

Summary: This study aimed to analyze the body mass index (BMI) trajectories of children exposed to gestational diabetes mellitus (GDM) from birth to 10 years old and associate them with infant and maternal characteristics. The study identified three distinct BMI trajectories for children exposed to GDM, which were normal, late accelerating, and early accelerating. These BMI trajectories were associated with infant and maternal characteristics.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Endocrinology & Metabolism

Faster-acting insulin aspart versus insulin aspart in the treatment of type 1 or type 2 diabetes during pregnancy and post-delivery (CopenFast): an open-label, single-centre, randomised controlled trial

Sidse K. Norgaard, Julie C. Soholm, Elisabeth R. Mathiesen, Kirsten Norgaard, Tine D. Clausen, Pernille Holmager, Nicoline C. Do, Peter Damm, Lene Ringholm

Summary: The study found that using faster aspart compared to insulin aspart in pregnant women with diabetes did not pose additional safety issues, and resulted in similar effects on fetal growth and maternal indicators.

LANCET DIABETES & ENDOCRINOLOGY (2023)

Review Endocrinology & Metabolism

Prediction and prevention of preeclampsia in women with preexisting diabetes: the role of home blood pressure, physical activity, and aspirin

Nicoline Callesen Do, Marianne Vestgaard, Sidse Kjaerhus Norgaard, Peter Damm, Elisabeth R. Mathiesen, Lene Ringholm

Summary: Women with type 1 or type 2 diabetes are more likely to develop preeclampsia. Blood pressure monitoring, physical activity, and prophylactic aspirin may help decrease the prevalence of preeclampsia in women with preexisting diabetes.

FRONTIERS IN ENDOCRINOLOGY (2023)

Article Endocrinology & Metabolism

Health promotion intervention among women with recent gestational diabetes mellitus: penetration, participation, and baseline findings from the Face-it randomized controlled trial

Nanna Husted Jensen, Karoline Kragelund Nielsen, Inger Katrine Dahl-Petersen, Ulla Kampmann, Peter Damm, Per Ovesen, Elisabeth Reinhardt Mathiesen, Christina Anne Vinter, Emma Davidsen, Maja Thogersen, Anne Timm, Lise Lotte Torvin Andersen, Sine Knorr, Dorte Moller Jensen, Helle Terkildsen Maindal

Summary: The Face-it trial is a randomized controlled trial for women with recent gestational diabetes mellitus (GDM) and their families. The penetration and participation rates were acceptable, with participating women showing slight differences in characteristics based on partner participation status.

BMJ OPEN DIABETES RESEARCH & CARE (2023)

Article Endocrinology & Metabolism

Applying WHO2013 diagnostic criteria for gestational diabetes mellitus reveals currently untreated women at increased risk

Cathrine Munk Scheuer, Dorte Moller Jensen, H. David McIntyre, Lene Ringholm, Elisabeth Reinhardt Mathiesen, Celina Pforr Korsgard Nielsen, Runa Louise Mortansdottir Nolsoe, Julie Milbak, Thore Hillig, Peter Damm, Martin Overgaard, Tine Dalsgaard Clausen

Summary: This study aims to compare the prevalence of gestational diabetes mellitus (GDM) in a Danish cohort using the current Danish criteria and the WHO2013 criteria, and evaluate the adverse pregnancy outcomes among untreated women who fall between the diagnostic thresholds. The results showed a significantly higher GDM prevalence when using the WHO2013 criteria compared to the Danish criteria, and untreated GDM in the gap between the two criteria resulted in higher risks of adverse pregnancy outcomes.

ACTA DIABETOLOGICA (2023)

Meeting Abstract Endocrinology & Metabolism

Copenfast trial: foetal growth and glycaemic control in pregnant women with type 1 or type 2 diabetes randomised to faster-acting insulin aspart or insulin aspart

S. Norgaard, J. Soholm, E. Mathiesen, K. Norgaard, T. Clausen, P. Holmager, N. Do, P. Damm, L. Ringholm

DIABETOLOGIA (2023)

Meeting Abstract Endocrinology & Metabolism

Delayed attainment of recommended glycaemic metrics in target in women with type 1 diabetes delivering large for gestational age infants

J. C. Soholm, S. K. Norgaard, N. C. Do, K. Norgaard, T. D. Clausen, P. Damm, E. R. Mathiesen, L. Ringholm

DIABETOLOGIA (2023)

Letter Endocrinology & Metabolism

Pregnancy outcomes in women with type 1 diabetes using insulin degludec: response to Kamran et al

Lene Ringholm, Nicoline Callesen Do, Peter Damm, Elisabeth Reinhardt Mathiesen

ACTA DIABETOLOGICA (2023)

暂无数据